ECDC has launched an online platform, RespiCompass, which uses mathematical modelling to simulate respiratory disease dynamics under different scenarios.

Strengthening of nonpharmaceutical interventions changed the epidemic dynamics of pediatric infectious diseases, with a trend toward older hospitalized children.

Based on the current risk assessment, WHO advises against any travel or trade restrictions related to current trends in acute respiratory infections.

Respiratory infections can increase the risk of cardiovascular diseases among all people. Studies show that for CVD patients diagnosed with flu, the risk of experiencing a heart attack increases 6-fold.

This report covers the period from August 2023 to August 2024, highlighting the latest developments within the vaccine industry and how these innovations are addressing existing and upcoming health threats.

In conclusions recently approved, the Council puts forward a series of measures aimed at improving cardiovascular health in the EU, focusing specifically on prevention, early detection, treatment and rehabilitation.

ECDC’s annual conference took place from 20-22 November in Stockholm, bringing together hundreds of public health professionals—from epidemiologists to veterinarians, microbiologists, clinicians, and more.

Influenza vaccine effectiveness (VE) is commonly assessed against prevention of illness that requires medical attention. Few studies have evaluated VE against secondary influenza infections.

IDC launched a social media campaign to highlight the impact of influenza on people living with diabetes and the crucial importance of influenza vaccine uptake for this risk group.

Tools for rapid identification of novel and/or emerging viruses are urgently needed for clinical diagnosis of unexplained infections and pandemic preparedness.

Despite the availability of updated seasonal influenza vaccines and treatments, annual influenza epidemics continue to cause millions of hospitalizations and substantial burden on health care systems.

While the estimated number of U.S. influenza-associated deaths is reported annually, detailed data on the epidemiology of influenza-associated deaths, including the burden of in-hospital versus post-hospital discharge deaths are limited.